Vanguard VBK vs. iShares IJT: How These Small-Cap Growth ETFs Compare on Fees, Risk, and Returns

The piece compares Vanguard Small-Cap Growth ETF (VBK) and iShares S&P Small-Cap 600 Growth ETF (IJT), highlighting VBK's lower expense ratio (0.07% vs. 0.18%), much larger AUM ($39B vs. $6B) and stronger one‑year return (12.47% vs. 8.63%), against higher five‑year max drawdown (-38.39% vs. -29.23%) and greater volatility (beta 1.43 vs. 1.18). Sector tilts differ materially — VBK holds 27% tech, 21% industrials and 18% healthcare across ~552 positions, while IJT is more evenly split (20% tech, 19% industrials, 17% healthcare) with ~348 stocks — and IJT yields 0.91% versus VBK's 0.54%. The comparison implies VBK offers lower fees and higher recent returns with higher risk and tech concentration, whereas IJT may suit income- or stability‑oriented small‑cap growth investors.

Analysis

Market structure: Vanguard (VBK) is the structural winner — lower expense (0.07% vs 0.18%), $39B AUM and broader 552-stock footprint create a self-reinforcing flow advantage that will bid up small-cap growth, especially tech-oriented names, if differential inflows persist. Losers are higher-fee small-cap wrappers (IJT) and income-focused buckets if flows rotate away; larger AUM concentration in VBK raises potential liquidity/impact risk in idiosyncratic selloffs.

Risk assessment: Key tail risks are a short, sharp Fed-driven repricing (CPI surprise >0.5% m/m or two 25bp hikes within 90 days) that could compress small-cap growth valuations and widen credit spreads; regulatory shocks to tech or biotech (FDA/FTC actions) are second-order threats. Immediate (days) risk centers on FOMC/CPI and weekly flows, short-term (1–3 months) on reconstitution/quarter-end flows, and long-term (6–24 months) on rate path and secular tech earnings growth.

Trade implications: Favor relative exposure not gross market beta — long VBK vs short IJT to capture tech-small-cap premium while neutralizing market risk; size positions to 2–3% notional and use options to cap downside. Expect rising small-cap implied vol (options skew) into macro events, creating attractive premia for protective puts or selling short-dated OTM calls against IJT income exposure.

Contrarian angles: The market underestimates AUM-concentration risk: VBK’s size can amplify drawdowns (5y max drawdown -38% vs -29% for IJT) so pure long VBK is riskier than headline outperformance implies. Fee advantage may be largely priced — real alpha comes from active exploitation of sector tilts (tech vs industrials/healthcare) and tactical volatility trades around macro catalysts.

Key Decisions for Investors

• Establish an equal-dollar pair: long VBK 2.5% portfolio weight and short IJT 2.5% for a 6–12 month trade to capture tech-small-cap tilt. Exit if VBK underperforms IJT by 7% within 3 months or trim both legs if spread narrows < -3% with a hard stop of 5% loss per leg.
• Buy 3-month VBK puts 10% OTM sized to protect 50% of the long VBK notional (limit premium to ≤0.6% of protected notional) to cap tail risk ahead of CPI/FOMC windows; roll or unwind if realized IV <16% and macro calm persists.
• For income, initiate IJT long at 1–1.5% weight (funded by trimming 1–1.5% large-cap growth) and sell 30-day covered calls 3–5% OTM, roll monthly; target 6–8% annualized option income while capping downside with 5% stop-loss.
• Tactical macro hedge: buy a 60-day VIX call spread (long 25 strike, short 35 strike) sized to 0.5% portfolio ahead of next two FOMC/CPI prints (90 days). Unwind if VIX settles below 16 and realized volatility expectation normalizes.
• Monitor triggers and rebalance: if VBK net inflows >$5B in a quarter or VBK drawdown reapproaches -35%, reduce VBK exposure by 25% and rotate into IJT/healthcare small-caps or cash within 7 trading days.